Picture of Catalyst Pharmaceuticals logo

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Catalyst Pharmaceuticals Q1 Revenue USD 85.4 Mln

May 10 (Reuters) - Catalyst Pharmaceuticals Q1 adjusted net income USD 46.8
million.
* Q1 net income USD 29.6 million
* Outlook FY revenue USD 375-385 million
* Q1 operating income USD 35.6 million
* Q1 revenue USD 85.4 million

Recent news on Catalyst Pharmaceuticals

See all news